Humoral immune responses during a malaria vaccine trial in Tanzanian infants (Q43951508)

28 November 2017

Humoral immune responses during a malaria vaccine trial in Tanzanian infants (English)

1 reference

28 November 2017

0 references

0 references

1 reference

15

Tanner M

1 reference

28 November 2017

Galindo CM

1

1 reference

28 November 2017

Acosta CJ

2

1 reference

28 November 2017

Schellenberg D

3

1 reference

28 November 2017

Aponte JJ

4

1 reference

28 November 2017

Roca A

5

1 reference

28 November 2017

Oettli A

6

1 reference

28 November 2017

Urassa H

7

1 reference

28 November 2017

Armstrong Schellenberg J

8

1 reference

28 November 2017

Kahigwa E

9

1 reference

28 November 2017

Ascaso C

10

1 reference

28 November 2017

Mshinda H

11

1 reference

28 November 2017

Lwilla F

12

1 reference

28 November 2017

Vidal J

13

1 reference

28 November 2017

Menendez C

14

1 reference

28 November 2017

Alonso PL

16

1 reference

28 November 2017

1 September 2000

1 reference

28 November 2017

1 reference

28 November 2017

22

1 reference

28 November 2017

9

1 reference

28 November 2017

437-443

1 reference

A longitudinal study of seroreactivities to Plasmodium falciparum antigens in Nigerian infants during their first year of life

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Potential and limitations of polysaccharide vaccines in infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Gamma-globulin and acquired immunity to human malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Efficacy trial of malaria vaccine SPf66 in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Potentials and limitations of protein vaccines in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

The SPf66 Malaria Vaccine: What is the Evidence for Efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Serological responses of Gambian children to immunization with the malaria vaccine SPf66.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

21 January 2018

Motherhood and malaria.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Induction of protective immunity against experimental infection with malaria using synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3024.2000.00322.X

10.1046/J.1365-3024.2000.00322.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference